Home Journals Articles Updates About
CN
image
收藏切换
Research progress on the relationship of antiviral therapy with HCV-hepatocellular carcinoma
收藏切换
PDF
Ya Deng1, 2, Chun-Yan Wang2, Dong Ji1, 2, *
Medical Journal of Chinese People’s Liberation Army | 2023, 48(4) : 468 - 475
Less
收藏切换
Medical Journal of Chinese People’s Liberation Army | 2023, 48(4): 468-475
• Review •
Research progress on the relationship of antiviral therapy with HCV-hepatocellular carcinoma
Full
Ya Deng1, 2, Chun-Yan Wang2, Dong Ji1, 2, *
Affiliations
  • 1The Second School of Clinical Medicine, Southern Medical University, Guangzhou, Guangdong 510515, China
  • 2Senior Department of Hepatology, the Fifth Medical Center of Chinese PLA General Hospital, Beijing 100039, China
Published: 2023-04-28 doi: 10.11855/j.issn.0577-7402.2023.04.0468
Outline
收藏切换

Chronic hepatitis C virus (HCV) is a worldwide epidemic and the main cause of liver cirrhosis and hepatocellular carcinoma (HCC). The anti-HCV treatment has gone through two eras of pegylated interferon-α plus ribavirin (PR therapy) and direct-acting antiviral agent (DAA). Generally, achieving a sustained virological response (SVR) can reduce the incidence of HCC through antiviral treatment. In recent years, increasing researchers pay more attention to the issue whether DAA treatment might increase the risk of HCC occurrence or recurrence. This article aims to review the related studies on the risk of HCC after PR therapy and DAA treatment, summarize the risk factors, and explore the mechanism of HCC and its impact on the efficacy of DAA, in order to help clinicians to determine the timing of initiation of antiviral therapy and provide clinical evidence for individualized management.

hepatitis C virus  /  pegylated interferon-α plus ribavirin therapy  /  direct-acting antiviral therapy  /  hepatocellular carcinoma
Ya Deng, Chun-Yan Wang, Dong Ji. Research progress on the relationship of antiviral therapy with HCV-hepatocellular carcinoma[J]. Medical Journal of Chinese People’s Liberation Army, 2023 , 48 (4) : 468 -475 . DOI: 10.11855/j.issn.0577-7402.2023.04.0468
Funding
Less
  • Medical Big Data and Artificial Intelligence Development Fund of Chinese PLA General Hospital(2019MBD-024)
Appendix
Less
Year 2023 volume 48 Issue 4
PDF
158
62
Cite this Article
BibTeX
Article Info
doi: 10.11855/j.issn.0577-7402.2023.04.0468
  • Receive Date：2021-12-29
  • Online Date：2025-12-03
  • Published：2023-04-28
Article Data
Affiliations
History
  • Received：2021-12-29
  • Accepted：2022-03-23
Funding
Medical Big Data and Artificial Intelligence Development Fund of Chinese PLA General Hospital(2019MBD-024)
Affiliations
    1The Second School of Clinical Medicine, Southern Medical University, Guangzhou, Guangdong 510515, China
    2Senior Department of Hepatology, the Fifth Medical Center of Chinese PLA General Hospital, Beijing 100039, China

Corresponding:

References
Share
https://castjournals.cast.org.cn/joweb/jfjyxzz/EN/10.11855/j.issn.0577-7402.2023.04.0468
Share to
QR

Scan QR to access full text

Cite this article
BibTeX
Citations
表12种不同金属材料的力学参数
科
Family		 属数
Number of
genus		 种数
Number of
species		 占总种数比例
Percentage of
total species (%)		 属
Genus		 种数
Number of
species		 占总种数比例
Percentage of total
species (%)
鹅膏菌科Amanitaceae 2 11 5.26 鹅膏菌属 Amanita 10 4.78
小菇科 Mycenaceae 2 12 5.74 丝盖伞属 Inocybe 5 2.39
多孔菌科 Polyporaceae 8 14 6.70 蜡蘑属 Laccaria 5 2.39
红菇科 Russulaceae 3 23 11.00 小皮伞属 Marasmius 6 2.87
小菇属 Mycena 11 5.26
光柄菇属 Pluteus 5 2.39
红菇属 Russula 17 8.13
栓菌属 Trametes 5 2.39
关闭全屏
  • BibTeX
  • EndNote
  • RefWorks
  • TxT
Links
Articles
Latest Articles
Most Read
Collections
Updates
Events
News
Multimedia
About
About Us
Contact
No. 86 Xueyuan South Road, Haidian District, Beijing
100081
010-62199257
qkjq@cast.org.cn

Copyright © 2025 China Association for Science and Technology. All rights reserved. For all open access content, the relevant licensing terms apply.
Sponsored by the Office of the Leading Group for Cybersecurity and Informatization of CAST, and supported by Science and Technology Review Publishing House